Ocimum gratissimum extract reduced colorectal cancer (CRC) tumor load. Continuous administration was more effective than separated administration. OGE also reduced severe colitis, suggesting potential for preventing CRC by inhibiting inflammation.
Opuntia spp. has potential as an anticancer agent with effects on colorectal, melanoma, and breast cancer through apoptosis, cell cycle arrest, and oxidative stress. More studies, including animal experiments and clinical trials, are needed.
YIV-818-A, a botanical drug derived from Rubia cordifolia extracts, effectively inhibits castration-resistant prostate cancer (CRPC) and shows synergy with existing drugs. It has potential as an anti-prostate cancer drug with chemopreventive properties.
This study analyzed the biochemical constituents of plant leaves using FTIR and GC-MS. They found compounds with health benefits, such as omega-3 fatty acids. The leaves also exhibited antimicrobial and antioxidant activity, as well as anticancer activity. These findings suggest their potential use in nutraceuticals and functional foods.
Oxymatrine, a natural alkaloid, has antiviral, anti-inflammatory, and immune regulatory effects. Research suggests it may be beneficial for lung cancer patients with COVID-19. Targets include immune regulation, cytoprotection, and control of signaling pathways. Oxymatrine may enhance current treatments for COVID-19 and lung cancer.
Nigeria has the highest burden of schistosomiasis in the world. This review summarizes the distribution, prevalence, diagnosis, treatment, and preventive measures. Limited use of diagnostic tools and preventive chemotherapy contribute to the high endemicity in Nigeria. The country has potential for discovering biomarkers and novel plant-derived treatments.
Scientists studied the plant Terminalia arjuna, which is traditionally used in India for treating diseases. Its potential pharmacological activities are being investigated for potential use in repurposing drugs. Relevant for drug development.